0.80Open0.80Pre Close0 Volume1.52K Open Interest5.00Strike Price0.00Turnover95.19%IV12.13%PremiumJul 19, 2024Expiry Date0.22Intrinsic Value100Multiplier5DDays to Expiry0.58Extrinsic Value100Contract SizeAmericanOptions Type-0.6276Delta0.6854Gamma13.66Leverage Ratio-0.0198Theta-0.0005Rho-8.57Eff Leverage0.0022Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet